SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000093751-16-000571
Filing Date
2016-04-08
Accepted
2016-04-08 14:00:55
Documents
1

Document Format Files

Seq Description Document Type Size
1 CELLDEX THERAPEUTICS, INC CLDX.txt SC 13G 6727
  Complete submission text file 0000093751-16-000571.txt   8758
Mailing Address ONE LINCOLN STREET BOSTON MA 02111
Business Address ONE LINCOLN STREET BOSTON MA 02111 617 786-3000
STATE STREET CORP (Filed by) CIK: 0000093751 (see all company filings)

IRS No.: 042456637 | State of Incorp.: MA | Fiscal Year End: 0219
Type: SC 13G
SIC: 6022 State Commercial Banks

Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Subject) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-37761 | Film No.: 161562285
SIC: 2835 In Vitro & In Vivo Diagnostic Substances